Olanzapine

Product NDC: 64725-0751
11-digit product format: 647250751
Labeler code: 64725
Product ID: 64725-0751_0c423960-d654-405a-9c7e-75786213899f
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Olanzapine
Dosage form: TABLET, ORALLY DISINTEGRATING
Route: ORAL
Labeler: TYA Pharmaceuticals
Application: ANDA090881
Marketing category: ANDA
Marketing start: 2012-02-28
Marketing end: 0000-00-00
Substance: OLANZAPINE
Active strength: 5 mg/1
Pharmacologic classes: Atypical Antipsychotic [EPC]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	64725-0751		I	Inactivated by FDA		2026-10-05
excluded package	package	64725-0751	64725-0751-1	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64725-0751-1	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64725-0751-1	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64725-0751-1	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64725-0751-1	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64725-0751-1	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64725-0751-1	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64725-0751-1	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64725-0751-1	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64725-0751-1	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	64725-0751-1	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	64725-0751-1	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	64725-0751-1	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	64725-0751-1	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	64725-0751-1	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	64725-0751-1	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	64725-0751-1	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	64725-0751-1	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	64725-0751-1	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	64725-0751-1	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	64725-0751-1	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	64725-0751-1	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	64725-0751-1	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A090881-001	OLANZAPINE	OLANZAPINE	5MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28
A090881-002	OLANZAPINE	OLANZAPINE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28
A090881-003	OLANZAPINE	OLANZAPINE	15MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28
A090881-004	OLANZAPINE	OLANZAPINE	20MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A090881-001	OLANZAPINE	5MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A090881-002	OLANZAPINE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A090881-003	OLANZAPINE	15MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A090881-004	OLANZAPINE	20MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A090881-001	OLANZAPINE	5MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A090881-002	OLANZAPINE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A090881-003	OLANZAPINE	15MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A090881-004	OLANZAPINE	20MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A090881-001	OLANZAPINE	5MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090881-002	OLANZAPINE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090881-003	OLANZAPINE	15MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090881-004	OLANZAPINE	20MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090881-001	OLANZAPINE	5MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090881-002	OLANZAPINE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090881-003	OLANZAPINE	15MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090881-004	OLANZAPINE	20MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A090881-001	OLANZAPINE	5MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090881-002	OLANZAPINE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090881-003	OLANZAPINE	15MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090881-004	OLANZAPINE	20MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090881-001	OLANZAPINE	5MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090881-002	OLANZAPINE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090881-003	OLANZAPINE	15MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090881-004	OLANZAPINE	20MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090881-001	OLANZAPINE	5MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090881-002	OLANZAPINE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090881-003	OLANZAPINE	15MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090881-004	OLANZAPINE	20MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090881-001	OLANZAPINE	5MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090881-002	OLANZAPINE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090881-003	OLANZAPINE	15MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090881-004	OLANZAPINE	20MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090881-001	OLANZAPINE	5MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090881-002	OLANZAPINE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090881-003	OLANZAPINE	15MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090881-004	OLANZAPINE	20MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090881-001	OLANZAPINE	5MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090881-002	OLANZAPINE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090881-003	OLANZAPINE	15MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090881-004	OLANZAPINE	20MG	TABLET, ORALLY DISINTEGRATING / ORAL	2012-02-28	`5bbf6a4d5a75…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 108 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2024-05-31 18:47 UTC	2024-05	A090881-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A090881-002	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A090881-003	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A090881-004	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090881-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090881-002	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090881-003	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090881-004	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A090881-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A090881-002	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A090881-003	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A090881-004	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A090881-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A090881-002	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A090881-003	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A090881-004	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A090881-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090881-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090881-003	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090881-004	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A090881-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A090881-002	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A090881-003	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A090881-004	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A090881-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A090881-002	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A090881-003	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A090881-004	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A090881-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A090881-002	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A090881-003	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A090881-004	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A090881-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A090881-002	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A090881-003	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A090881-004	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A090881-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A090881-002	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A090881-003	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A090881-004	AB	1	`8869cabd3fbd…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
42e9462d-db65-453b-8069-8fb2df9182e8	Product name	1	20211216
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
12d02c27-e8da-47f1-b815-ccca982731ef	Product name	9	20170802
877783eb-030c-6e3f-0979-804cf94d8856	Product name	1	20140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
64725-0751-1	2020-01-31	C162847	48780-1	9d75b9d1-14af-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use olanzapine safely and effectively. See full prescribing information for olanzapine orally disintegrating tablets. Olanzapine Orally Disintegrating Tablets, for Oral use Initial U.S. Approval: 1996

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
OLANZAPINE	ACTIVE INGREDIENT	N7U69T4SZR	OLANZAPINE TABLET, ORALLY DISINTEGRATING [TYA PHARMACEUTICALS]	4
OLANZAPINE	ACTIVE MOIETY	N7U69T4SZR	OLANZAPINE TABLET, ORALLY DISINTEGRATING [TYA PHARMACEUTICALS]	4
ASPARTAME	INACTIVE INGREDIENT	Z0H242BBR1	OLANZAPINE TABLET, ORALLY DISINTEGRATING [TYA PHARMACEUTICALS]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	OLANZAPINE TABLET, ORALLY DISINTEGRATING [TYA PHARMACEUTICALS]	4
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	OLANZAPINE TABLET, ORALLY DISINTEGRATING [TYA PHARMACEUTICALS]	4
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	OLANZAPINE TABLET, ORALLY DISINTEGRATING [TYA PHARMACEUTICALS]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	OLANZAPINE TABLET, ORALLY DISINTEGRATING [TYA PHARMACEUTICALS]	4
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	OLANZAPINE TABLET, ORALLY DISINTEGRATING [TYA PHARMACEUTICALS]	4
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	OLANZAPINE TABLET, ORALLY DISINTEGRATING [TYA PHARMACEUTICALS]	4